Small molecule inhibitor
This page covers all Small molecule inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Specific protein involved in cancer cell proliferation, DNA repair enzyme, Specific protein involved in disease pathways.
Targets
Specific protein involved in cancer cell proliferation · DNA repair enzyme · Specific protein involved in disease pathways · Specific protein kinase · [specific protein] · [specific target] · JAK3/STAT3 pathway · Enzyme X · Unknown
Marketed (11)
- Pf-07921585 · Pfizer · Oncology
- Treatment Choice · Astex Pharmaceuticals, Inc. · Oncology
- Pf-08052666 · Pfizer · Other
- PF-06939999 in combination with docetaxel · Pfizer · Oncology
- Pf-08046045 · Pfizer · Oncology
- Pf-07853578 · Pfizer · Other
- Pf-06954522 · Pfizer · Rare Disease
- Ritlecitinib 20 mg · Pfizer · Dermatology
- Pf-07220060 · Pfizer · Oncology
- Pf-07248144 · Pfizer · Oncology
- Treament C · Rennes University Hospital · Cardiovascular
Treatment C works by inhibiting the activity of a specific enzyme.
Phase 3 pipeline (1)
- TBICy · The First Affiliated Hospital of Soochow University · Neurology
TBICy is a small molecule that inhibits the activity of a specific enzyme.
Phase 2 pipeline (2)
- KD7040 Topical Gel · Kalypsys, Inc. · Dermatology
KD7040 Topical Gel is a topical gel formulation of a small molecule inhibitor. - ARTICE · Artcline GmbH · Cardiovascular
ARTICE is a small molecule that targets the underlying cause of a specific disease.